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Abstract A co-culture system was used to study the effect of
reactive nitrogen species (RNS) generated by RAW 264.7
macrophages grown on filters and activated by lipopolysaccha-
ride and interferon-Q, on the K-tocopherol levels in ECV 302
endothelial cells. The results indicate that: RNS generated by
activated macrophages or by direct administration of peroxyni-
trite lead to a significant loss of K-tocopherol in endothelial cells ;
pre-incubation with procyanidin extracted from pine bark
(Pycnogenol) protects K-tocopherol of endothelial cells and
enhances by about 15% basal endogenous levels of K-tocopherol.
These results demonstrate flavonoids participate in the cellular
antioxidant network and suggest that Pycnogenol may play an
important role in the protection of endothelium from oxidative
stress induced by reactive nitrogen species.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
It is widely accepted that endothelial cell dysfunction is
associated with an alteration in the cell redox status [1]. Vita-
min E and in particular K-tocopherol is an essential compo-
nent of the cellular antioxidant network which has been re-
ported to exert a protective activity against cardiovascular
diseases [2]. This e¡ect is due either to its chain-breaking
antioxidant activity in the lipid component of the cell, or to
a speci¢c regulatory function toward key enzymes involved in
cell growth and di¡erentiation [3].
When K-tocopherol levels are challenged by reactive oxygen
species (ROS) and reactive nitrogen species (RNS), e.g. nitric
oxide (NO) or peroxynitrite (ONOO3), produced during pro-
oxidative conditions such as in an in£ammatory response, the
whole cellular antioxidant network participates in maintaining
the redox homeostasis compatible with cell functions [4].
Many plant phenolics and in particular some £avonoids
possessing a strong antioxidant activity may also participate
in antioxidant cell defenses either by e⁄ciently scavenging
both ROS and RNS, or by recycling ascorbate [5], and there-
fore may exert an K-tocopherol ‘sparing e¡ect’ [6].
Di¡erent plant extracts have been used in the traditional
medicine as remedies for circulatory diseases. Pycnogenol is
the proprietary extract from the bark of Pinus marittima
composed from phenolic molecules, broadly divided into
monomers (catechin, epicatechin and taxifolin) and mainly
condensed £avonoids classi¢ed as procyanidins/pro-anthocya-
nidins (oligomeric procyanidins). Pycnogenol also contains
phenolic acids (such as ca¡eic, ferulic and p-hydroxybenzoic
acids) as minor constituents and glycosylation products, i.e.
glucopyranose derivatives of either £avanols or phenolic acids
as lesser constituents [7]. Pycnogenol has been reported to
enhance the antioxidant capacity of cultured endothelial cells
by speci¢cally increasing enzyme expression [8] and to protect
them from organic peroxide-induced oxidative stress [8,9].
Further it has been demonstrated that Pycnogenol is a power-
ful ROS and RNS scavenger and it is able to modulate NO
metabolism in activated macrophages [10].
Macrophages are the principal in£ammatory cell type found
in the atheromatous plaque microenvironment [11]. They in-
teract with endothelial cells, smooth muscle cells and lympho-
cytes through a wide spectrum of di¡erent sensor and signal
transducers between the endothelium and circulating blood
cells. Activated macrophages produce massive amounts of
ROS and RNS, generating a pro-oxidant environment which
in turn further triggers cell responses through activation of the
NF-UB transcription factor inducing a circular mechanism
¢nally leading to endothelial cell dysfunction [12].
In this study we have utilized a novel co-culture system
comprised of activated macrophages and endothelial cells sep-
arated by a ¢lter to study, after macrophage activation the
e¡ect of a long term, sustained production of NO, at physio-
logical concentrations, on K-tocopherol levels in the endothe-
lial cells. The protective e¡ect on K-tocopherol level by the
standardized procyanidins-containing extract from the pine
bark (Pycnogenol) in endothelial cells challenged either by
activated macrophages or by direct addition of ONOO3
was also investigated.
2. Materials and methods
2.1. Cell culture and treatments
ECV 304 and RAW 264.7 (obtained from the American Type Cul-
ture Collection, Rockville, MD, USA) were maintained at 37‡C in 5%
CO2, and were grown and passaged according to standard protocols.
ECV 304 cells (human umbilical cord endothelial cell), are a spon-
taneously transformed immortal endothelial cell line established from
an apparently normal human umbilical cord. Cells were grown up to
90^100% con£uence in 6-well tissues culture plates (Falcon, Franklin
Lakes, NJ, USA), in 199 medium supplemented with 10% fetal calf
serum (FCS) (UCSF cell culture facilities) and streptomycin-penicillin
solution. K-Tocopherol concentration of the medium was adjusted to
20 WM by adding a concentrated D-K-tocopherol solution dissolved in
ethanol. The ¢nal ethanol concentration in the medium was less than
0.1%.
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RAW 264.7 cells, a murine line of monocyte-macrophages, were
seeded on 0.4 Wm pore size cell culture inserts (Falcon) and cultured
in D-MEM containing 10% FCS and antibiotics. RAW 264.7 were
activated with lipopolysaccharide (LPS) and Q-interferon (IFN-Q)
(Genzyme, Cambridge, MA, USA) at 25 ng/ml and 10 U/ml respec-
tively. After 1 h macrophages were transferred on the top of ECV
wells in direct contact with 199 medium, and then co-cultured for 24 h
at 37‡C.
Pycnogenol (Horphag Research Ltd., Guernsey) was dissolved in
dimethyl sulfoxide (DMSO) and added to ECV 304 culture medium at
the indicated concentrations. Cells were incubated in the presence of
Pycnogenol for at least 16 h and the treatment was not removed
unless indicated. The ¢nal DMSO concentration in the medium was
less than 0.1%. Control cells (no Pycnogenol added) were treated with
identical concentrations of DMSO.
ECV 304 cells were treated with 250 WM ONOO3 (Alexis, San
Diego, CA, USA) in PBS for 2 h at 37‡C after removing the medium.
The excess of H2O2 was removed by passing through a manganese
dioxide column. Actual ONOO3 concentration was assessed by meas-
uring the absorbance at 302 nm in 1 N NaOH. As negative controls,
treatments with ONOO3 were performed in parallel with a decom-
posed form of ONOO3 prepared from the same stock as the active
form and containing the same concentrations of nitrite and salts as
negative controls.
All other chemicals were purchased from Sigma (St. Louis, MO,
USA). HPLC reagents were from Fisher (Fair Lawn, NJ, USA).
2.2. Assessment of nitric oxide production and K-tocopherol
measurements
NO concentration in both ECV 304 and RAW 264.7 media was
assessed at the end of the co-culture, after the ¢lters containing RAW
264.7 cells were removed, as NO32 and total nitroso compound (NOx)
i.e. NO33 plus NO
3
2 , using the Griess reagent as described previously
[13].
K-Tocopherol and cholesterol in ECV 304 cells were simultaneously
measured by HPLC coupled with EC and UV detectors after hexane
extraction of the cell lysate as described [14] and K-tocopherol con-
centrations were normalized to cholesterol. Cholesterol levels were
observed to be not a¡ected by either Pycnogenol or macrophages
treatment (data not shown).
2.3. Statistics and data presentation
Data in histograms are presented as a mean þ S.D. of at least three
separate experiments performed in triplicate. Di¡erence between treat-
ments were analyzed by ANOVA and the minimum level of signi¢-
cance was de¢ned at P6 0.05.
3. Results
3.1. NO generation by activated macrophages
LPS and IFN-Q induce the expression of the inducible form
of nitric oxide synthase (iNOS). A signi¢cant amount of NO
is produced over a long term. NO spontaneously oxidizes
generating both nitrite (NO32 ) and nitrate (NO
3
3 ). Moreover,
when macrophages are stimulated the enzymatic machinery
producing O3c2 is also activated, eventually resulting in the
formation of ONOO3, which ¢nally decomposes into NO33 .
Therefore, the measurement of NO32 and total nitro com-
pounds (NOx), i.e. NO33 plus NO
3
2 in the medium following




3 are accumulated in the medium after RAW
264.7 macrophages stimulation with LPS and IFN-Q (see Fig.
1). Non-activated RAW 264.7 cells produce only low levels of
NO32 and NO
3
3 but 24 h after treatment of cells with LPS and
IFN-Q, the levels in the culture medium increased dramatically
from 2.5 þ 0.3 to 56.4 þ 1.2 and from 7.3 þ 0.9 to 138.2 þ 3.4
WM respectively. Pycnogenol alone had no e¡ect on the basal
production of both NO32 and NO
3
3 .
3.2. E¡ect of the co-culture of activated RAW 264.7
macrophage and ECV 304 endothelial cells on the
K-tocopherol levels in ECV 304 cells
The simultaneous production of ROS and RNS by acti-
vated macrophages induces a pro-oxidant environment which
challenges the antioxidant system of ECV 304 endothelial
cells. After 24 h of exposure to activated RAW 267.4 macro-
phages, K-tocopherol level of control ECV 304 cells (no pre-
treatment with Pycnogenol) was signi¢cantly lower in compar-
ison to cells which were co-cultured with non-activated mac-
rophages (Fig. 2). Co-culture with non-activated RAW 264.7
did not a¡ect the K-tocopherol levels in ECV 304 endothelial
cells (data not shown).
The pre-incubation of ECV 304 endothelial cells with Pyc-
nogenol was associated with a signi¢cant protection from K-
tocopherol loss. Treatment with 10 Wg/ml Pycnogenol was
associated with signi¢cantly higher levels of K-tocopherol,
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Fig. 1. NO32 and NO
3
3 production by RAW 267.4 monocyte-macro-
phages cells after LPS and IFN-Q treatment. Bars represent the
mean þ S.D. of at least three di¡erent experiments performed in
triplicate.
Fig. 2. K-Tocopherol levels and e¡ect of 24 h preincubation with
Pycnogenol in ECV 304 endothelial cells after the exposure to
RAW 264.7 macrophages activated by LPS and IFN-Q. Bars repre-
sent the mean þ S.D. of at least three di¡erent experiments per-
formed in triplicate. *Signi¢cant from ‘non-activated RAW’ within
the same pre-treatment. Signi¢cant from control cells.
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even in the absence of the exposure to RNS and ROS, indi-
cating that procyanidins from pine bark a¡ected cellular re-
dox status in the basal condition. However, higher concentra-
tions of Pycnogenol in the medium (50 Wg/ml) were associated
both with lower levels of K-tocopherol and with a less evident
protection.
When Pycnogenol was removed from the medium before
the exposure to macrophages, a lesser protective e¡ect was
observed, suggesting that some interaction between oxidizing
species and £avonoids occurred in the medium. At the highest
concentration tested, the removal of Pycnogenol from the
medium, was not associated with any signi¢cant di¡erence
in K-tocopherol levels in EVC 302 endothelial cells after the
exposure to activated RAW 264.7 macrophages.
3.3. Protective activity of Pycnogenol on ONOO3 induced
K-tocopherol loss in ECV endothelial cells
Due to the simultaneous production of NO and superoxide
(O3c2 ) in the course of macrophage activation, the generation
of ONOO3 is likely to occur. ONOO3 is a more reactive pro-
oxidant species than NO and O3c2 radicals, and it has been
proposed as a causative factor in cell injury. In order to assess
if Pycnogenol could protect K-tocopherol from the direct ex-
posure to ONOO3, ECV 304 endothelial cells were incubated
for 2 h in the presence of 250 WM ONOO3.
Following incubation with ONOO3, K-tocopherol levels
of ECV 304 cells were signi¢cantly a¡ected(Fig. 3). A loss
of about 30% of the baseline K-tocopherol value was ob-
served in control cells. As in the previously described ex-
periments with activated macrophages, pre-incubation with
10 Wg/ml Pycnogenol was associated both with higher
baseline K-tocopherol levels and with protection of K-toco-
pherol after treatment with 250 WM ONOO3. At 25 Wg/ml
Pycnogenol in the pre-incubation medium, K-tocopherol
loss following ONOO3 treatment was not signi¢cant. It is
important that ONOO3 was administered to ECV 304 cells
in PBS, after washing away the culture medium, there-
fore eliminating the possibility of a direct interaction between
ONOO3 and Pycnogenol outside the cellular environ-
ment.
4. Discussion
In this study a novel co-culture system was utilized to dem-
onstrate that macrophage activation, such as occurs during
in£ammatory processes, challenges endothelial cell antioxi-
dant status, as indicated by a signi¢cant decrease of K-toco-
pherol levels. This model was characterized by a long-term,
sustained generation of high levels of RNS, thus mimicking
the occurrence of a mild ‘physiological’ oxidative stress. The
combination of two non-homo-speci¢c cell lines in the exper-
imental design (RAW 264.7, a murine derived cell line, with
ECV 304 endothelial cells of human origin) was chosen due to
the need of avoiding the activation of endothelial cells
through the species-speci¢c cytokine utilized for macrophage
activation. No e¡ect was observed either on K-tocopherol lev-
els or other functional cell parameters when ECV 304 cells
were exposed to the medium utilized for RAW 264.7 culture
after activation with LPS and IFN-Q.
We have previously demonstrated that Pycnogenol a¡ects
NO metabolism in the same monocyte-macrophage cell line
utilized here for the co-culture. In the present study RAW
264.7 macrophages were in contact with Pycnogenol only
after activation with LPS and IFN-Q, and in this condition
no e¡ect on NO32 or NO
3
3 production was observed [10].
This study demonstrates that the generation of relatively
high amounts of RNS by activated macrophages induces ox-
idative stress su⁄cient to alter the cellular antioxidant levels.
These results help to clarify the complex role of NO in the
endothelium, where it can act either as antioxidant [15] or as
pro-oxidant as suggested by the results reported herein and
previously [16,17], depending on the relative concentrations
between NO and ROS such as O3c2 . Alterations in endothelial
antioxidant levels eventually a¡ect the cellular functions
which, at least in part, are regulated by cellular redox status
such as the expression of NF-UB. This in turn plays a key role
in endothelial dysfunction and in atherogenesis [12].
The results also indicate that ONOO3 is able to signi¢-
cantly deplete K-tocopherol levels in endothelial cells. These
¢ndings are in agreement with other reports [18,19] con¢rming
the importance of K-tocopherol in RNS mediated oxidative
stress.
Another important ¢nding in this investigation is the dem-
onstration that £avonoids, and in particular the procyanidin
blend extracted from the bark of Pinus marittima, appear to
have an important e¡ect on the cellular antioxidant network
both in the basal condition, as indicated by higher K-toco-
pherol levels in ECV 304 cells pre-incubated with Pycnogenol,
and in pro-oxidant conditions induced by RNS, such as those
due to the exposure to activated macrophages or to the direct
administration of ONOO3. Phenolics, and in particular some
£avonoids, owing to their intermediate redox potential and
physico-chemical characteristics, can possibly act at the inter-
face between ascorbate and tocopherols. Ascorbic acid has
been shown to directly regenerate K-tocopherol from K-toco-
pherol radical in lipoproteins and membranes, and is thus an
integral part of the redox antioxidant-recycling network [20].
Pycnogenol has been shown to prolong ascorbyl radical life-
time [5] and can therefore contribute to prevent K-tocopherol
loss, possibly by the enhancing ascorbate protective e¡ect,
which is likely to be one of the primary mechanism of toco-
pheryl radical reduction. However, it was observed that the
highest concentration of Pycnogenol tested (50 Wg/ml) were
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Fig. 3. K-Tocopherol levels in ECV 304 endothelial cells after 2 h
exposure to 250 WM ONOO3 and e¡ect of 24 h preincubation with
Pycnogenol. Bars represent the mean þ S.D. of at least three di¡er-
ent experiments performed in triplicate. *Signi¢cant from ‘no
ONOO3 treatment’ within the same pre-treatment. Signi¢cant from
control cells.
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associated with both slightly lower K-tocopherol levels in
basal condition and to a lesser protection of ECV 304 endo-
thelial cells challenged by activated macrophages, suggesting
that high concentrations of phenolics may possibly have a
pro-oxidant activity in these experimental conditions.
The delicate interaction between endothelial cells and mac-
rophages is of interest. These cells interact together with lym-
phocytes and smooth muscle cells in determining the mainte-
nance of blood vessel homeostasis [21]. In particular,
endothelial cells participate in several aspects of vascular
physiology and physio-pathology, contributing to the control
and regulation of vessel tone, coagulation state, cell growth,
proliferation and death, and leukocyte tra⁄cking [22]. Occlu-
sive vascular diseases, such as atherosclerosis, are in fact char-
acterized by an abnormal proliferation of smooth muscle cells,
in£ammatory cells and extracellular matrix protein. Endothe-
lial cells dysfunction leads to vasoconstriction, thrombus for-
mation and in£ammatory cells in¢ltration into a plaque [22].
K-Tocopherol plays a key role in the maintenance of endo-
thelial functions and polyphenols may signi¢cantly contribute
in protecting this antioxidant during pro-oxidative events
[4,23]. Flavonoids and in general polyphenols are attracting
increasing interest as nutritional compounds recognized to
positively a¡ect human health and also for their potential
pharmacological activity. In recent years several di¡erent epi-
demiological reports have indicated that consumption of
foods rich in polyphenols is associated with lower incidence
of degenerative diseases [24] and experimental data are accu-
mulating regarding phenolic compounds as natural phyto-
chemical antioxidants important for human health [23]. The
ascorbate recycling activity displayed by various £avonoids [5]
confers to some plant extracts an important role in the cellular
antioxidant network and con¢rms the early reports by Szent-
Gyorgyi [25] who was the ¢rst investigator to propose phenols
as important bio-active molecules.
Hence, this study provides a background for the better
understanding of the complex activity of Pycnogenol and oth-
er related £avonoids, within the cellular antioxidant network,
and about RNS as possible causative factors of endothelial
dysfunction and cardiovascular disease.
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